The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary Arteries
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Ranolazine (Primary)
- Indications Ischaemia
- Focus Therapeutic Use
- 03 Jun 2017 Status changed from recruiting to withdrawn prior to enrolment.
- 13 May 2016 Status changed from not yet recruiting to recruiting.
- 25 Apr 2015 New trial record